Table 2.
Age range (years) | Beta (95% CI) | s.e. | P value | Females, na (%) |
---|---|---|---|---|
DHEAS <2040 nmol/L | ||||
Age 31–35 | 11.914 (8.540; −4.896) | 8.540 | 0.164 | 28 (10.7) |
Age 36–40 | −26.838 (11.073; −48.635) | 11.073 | 0.016 | 69 (25.8) |
Age 41–45 | −38.752 (10.920; −60.247) | 10.920 | <0.0001 | 94 (35.3) |
Age 46–50 | −55.901 (11.757; −79.043) | 11.757 | <0.0001 | 152 (56.8) |
Age 51–55 | −58.336 (12.112; −82.178) | 12.112 | <0.0001 | 162 (60.5) |
Age 56–60 | −69.109 (15.241; −99.109) | 15.241 | <0.0001 | 167 (62.5) |
A negative beta indicates a decline of DHEAS with increasing age.
aAll adult females (n = 268). Percent (number of cases <2040 nmol/L divided by 268).